Research Of Pelvic Inflammatory Disease Information

Pelvic Inflammatory Disease header image

Main Menu

Pelvic Inflammatory Disease Articles

Research Pelvic Inflammatory Disease

This articles looks at the statistics and research with Pelvic Inflammatory Disease, and discusses its implications.

Many women suffer from misdiagnoses’ and years of pain, which they soon discover after a bit of research, Pelvic Inflammatory Disease is responsible for. PID is an inflammation and infection in the woman’s reproductive organs, including the uterus, fallopian tubes (which carry the eggs from the ovary to the uterus), and/or the ovaries as well as any other organs that are related to reproduction.

The organs can become scarred, resulting in infertility, chronic pelvic pain, abscesses, ectopic pregnancy and other serious health concerns. Because of the prevalence of the disease and the consequences to women researchers continue to look for ways to improve the treatment protocols.

It has been said that PID is the most common cause of infertility in the United States, which could have been treated. Canadian statistics show that it is likely that one in 10 women will actually have at least one case of PID in their lives. Gonorrhea and Chlamydia are 2 of the most common causes of the disease, although there are other bacteria which can be responsible.

Women who are at the most risk for PID are those who are also at risk for sexually transmitted infections, as well as those who have already had an episode with PID. Women under the age of 25 who are sexually active are more susceptible due to the cervix, (which is the opening to the uterus), of teens and young women being more at risk of sexually transmitted infections. It is believed that their cervixes are not fully matured, which puts them at more risk of infection.

For some women, they will have no symptoms indicating PID and will never realize they are suffering from the illness until long term effects begin to show. Others will suffer from lower abdominal pain or cramping, foul smelling vaginal discharge, fever, irregular bleeding, abnormal discharge with pain and pain during intercourse. Symptoms will usually start to show right after a woman’s menstrual cycle. Pelvic Inflammatory Disease can actually be treated with a simple round of antibiotics, which is why early detection is essential to avoid the risk of infertility.

The best way to prevent the disease is, of course, to practice abstinence, or at the least be in a monogamous relationship with one partner who has been tested for sexually transmitted infections. Condoms can prevent the spread of gonorrhoea and Chlamydia as well, if used properly. You can also prevent yourself from getting PID by receiving early treatment if you do end up with a sexually transmitted infection.

It is so important to seek treatment early, since statistics indicate that each year, over 100,000 women will end up infertile, and more than 150 women will die as a result of PID and the many complications from the disease. If you feel you may be at risk, research Pelvic Inflammatory Disease and the complications and symptoms to be sure that you do all you can to protect yourself.

Videos

Research Of Pelvic Inflammatory Disease Headlines

Global Inflammatory Bowel Disease Therapeutics Market to Reach US $4.3 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

San Jose, CA (PRWEB) March 23, 2010 -- With growing incidence and prevalence of Inflammatory Bowel Disease (IBD), especially in temperate regions of North America and Europe, the IBD therapeutics...

Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases

New York, NY (Vocus) December 17, 2009 -- Three clinical and scientific thought-leaders in inflammatory bowel disease (IBD) research were awarded the Crohn's&Colitis Foundation's...

New York Times examines questions left unanswered by microbicide trial

The New York Times examines a set of questions raised by news out of the International AIDS Conference-AIDS 2010 last week that a microbicide gel containing the antiretroviral tenofovir used by women before and after sex helped reduce their risk of HIV infection by 39 percent.

Aoxing Pharmaceutical Company Reports Enrollment Progress On Phase III Clinical Trial Of TJSL Capsules

Aoxing Pharmaceutical Company, Inc. (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced the Company has enrolled over 120 patients in its on-going Phase III clinical studies of oral TJSL Capsules, a novel investigational drug to treat primary dysmenorrhea ("PD ...

Fear of having something in uterus deters teen girls from using intrauterine devices for birth control

Very few teenage girls in the United States use intrauterine devices for birth control, even though studies show they are safe, effective and extremely low-maintenance, according to researchers at Lucile Packard Children's Hospital and the Stanford School of Medicine.